Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease: the pathologist’s perspective
Wei Qiang Leow, Anthony W.H. Chan, Paulo Giovanni L. Mendoza, et al.
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S302-S318
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Liver cancer risk across metabolic dysfunction-associated steatotic liver disease and/or alcohol: a nationwide study
Byungyoon Yun, Heejoo Park, Sang Hoon Ahn, et al.
The American Journal of Gastroenterology (2024)
Closed Access | Times Cited: 8
Do Child–Turcotte–Pugh and nutritional assessments predict survival in cirrhosis: A longitudinal study
Randhall Bruce Carteri, Cláudio Augusto Marroni, Luis Fernando Ferreira, et al.
World Journal of Hepatology (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
A novel A2a adenosine receptor inhibitor effectively mitigates hepatic fibrosis in a metabolic dysfunction-associated steatohepatitis mouse model
Seojeong Park, Seohui Hwang, Jingyang Sun, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 5, pp. 1855-1870
Open Access | Times Cited: 7
Gut microbiome and nonalcoholic fatty liver disease
Mengyuan Wu, Jian‐Gao Fan
Hepatobiliary & pancreatic diseases international (2023) Vol. 22, Iss. 5, pp. 444-451
Closed Access | Times Cited: 14
Perilipins: A family of five fat‐droplet storing proteins that play a significant role in fat homeostasis
Preethi Chandrasekaran, Sabine Weiskirchen, Ralf Weiskirchen
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 6
Open Access | Times Cited: 5
Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review)
Junmin Wang, Jiacheng Li, Yugang Fu, et al.
International Journal of Molecular Medicine (2024) Vol. 53, Iss. 4
Open Access | Times Cited: 4
Extracellular vesicle-mediated approaches for the diagnosis and therapy of MASLD: current advances and future prospective
Swasthika Gurjar, R. A., Raghavendra Upadhya, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
Unraveling the molecular mechanisms of Fufangduzhong formula in alleviating high-fat diet-induced non-alcoholic fatty liver disease in mice
Yu Mou, Yao Tang, Xiuyan Zheng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Elevated red blood cell folate levels are associated with metabolic dysfunction-associated steatotic liver disease: results from NHANES 2017–2020
Xin Liao, Yu Song, Lin Wang, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
Investigating the Effects of Gossypetin on Liver Health in Diet-Induced Pre-Diabetic Male Sprague Dawley Rats
Karishma Naidoo, Andile Khathi
Molecules (2025) Vol. 30, Iss. 8, pp. 1834-1834
Open Access
Association of Stroke With Metabolic Dysfunction–Associated Fatty Liver Disease With and Without CKD
Yuhao Li, Shouling Wu, Jingli Gao, et al.
American Journal of Kidney Diseases (2023) Vol. 83, Iss. 4, pp. 477-488
Closed Access | Times Cited: 10
Prompting Vision Foundation Models for Pathology Image Analysis
Chong Yin, Siqi Liu, Kaiyang Zhou, et al.
2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) (2024) Vol. 33, pp. 11292-11301
Closed Access | Times Cited: 2
Proposal of a Novel Serological Algorithm Combining FIB-4 and Serum M2BPGi for Advanced Fibrosis in Nonalcoholic Fatty Liver Disease
Sang Yi Moon, Yang Hyun Baek, Se Young Jang, et al.
Gut and Liver (2023) Vol. 18, Iss. 2, pp. 283-293
Open Access | Times Cited: 4
Lipid droplet detection in histopathological images using reinforcement learning
Yoshitomi Harada, Haruto Nishida, Keiko Matsuura
Biotechnology & Biotechnological Equipment (2024) Vol. 38, Iss. 1
Open Access | Times Cited: 1
Female C57BL/6 Mice Exhibit Protection Against Nonalcoholic Fatty Liver Disease and Diabesity Accompanied by Differential Regulation of Hepatic Lipocalin Prostaglandin D2 Synthase
Md Asrarul Islam, Rhema Khairnar, Joshua S. Fleishman, et al.
Molecular and Cellular Endocrinology (2024) Vol. 595, pp. 112404-112404
Closed Access | Times Cited: 1
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association
Jaehyun Bae, Eugene Han, Hye Won Lee, et al.
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 6, pp. 1015-1028
Closed Access | Times Cited: 1
Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology
Yujin Zhu, Yue Zhang, Yao Rao, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 12, pp. 1407-1416
Open Access | Times Cited: 1
Evaluating the relative importance of different blood pressure indices in screening for NAFLD: a survey report based on a health examination population
Chong Hu, Ziqi Yu, Changli Wei, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice
Rose Willett, Volodymyr Tryndyak, J. Hanks, et al.
Toxicology and Applied Pharmacology (2024) Vol. 491, pp. 117046-117046
Closed Access
A peptide alleviated oxidative damages in the L02 cells and mice liver
Gan Gao, Zhiyang Zhang, Qiheng Wang, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 734, pp. 150643-150643
Closed Access
Targeting Long Non-Coding RNA H19 as a Therapeutic Strategy for Liver Disease.
Yulan Shi, F. Qu, Shiyun Zeng, et al.
Progress in Biophysics and Molecular Biology (2024)
Closed Access
Prediction of nonalcoholic fatty liver disease using machine learning
Shanthi Makka, Shivarla Naveen, Shyam Sai Kamal Puranam, et al.
Elsevier eBooks (2024), pp. 339-350
Closed Access
Transcription factor ETV4 plays a critical role in the development of non-alcoholic fatty liver disease
Bhavani Gadiraju, Jhansi Magisetty, Vijay Kondreddy
International Journal of Biological Macromolecules (2024) Vol. 282, pp. 137235-137235
Closed Access
<i>Arctium </i><i>lappa</i> L. Extract Alleviates Non-Alcoholic Fatty Liver Injury in Mices
娜 李
Hans Journal of Medicinal Chemistry (2024) Vol. 12, Iss. 04, pp. 309-313
Closed Access
Actualización del abordaje farmacológico de la enfermedad Esteatósica Asociada a Disfunción Metabólica
Xavier Ramon, Paola Verónica Orellana Bernal
Salud ConCiencia (2023) Vol. 2, Iss. 2, pp. e33-e33
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top